IP Library Granted Patent US 9,681,993
Granted Patent B2
US 9,681,993 · App. 13/490,844 · Granted Jun 20, 2017

Solutions for bridging and pressure concentration reduction at wound sites

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,681,993
App. No.
13/490,844
Granted
Jun 20, 2017
Kind
B2
Abstract

Disclosed herein are devices, systems and methods for delivering reduced pressure to a load-bearing wound site. The device can include a distal port configured to connect to a wound dressing positioned over the wound site; a proximal port located a distance from the distal port and configured to connect to a reduced pressure source, and a conduit body having an inner channel extending between the distal port and the proximal port. When the distal port is applied to the wound dressing positioned over the wound site the proximal port is positioned at a non-load bearing location remote from the wound dressing. The inner channel has a non-circular profile having a width larger than a height of the conduit body.

Claims (45)

1. An elongate conduit structure for providing reduced pressure therapy to a tissue site, the elongate conduit structure comprising:

an upper surface and a lower surface each extending along a longitudinal length of the elongate conduit structure;

a longitudinal passageway extending along the longitudinal length of the elongate conduit structure and between the upper surface and the lower surface;

an inlet opening located in the lower surface;

an outlet opening located in the upper surface;

a support structure defining parallel channels through the longitudinal passageway, wherein each of the parallel channels extends from the inlet opening to the outlet opening, and wherein the support structure comprises one or more elongate ribs coupled to at least one of the upper surface or the lower surface;

a port coupled to the upper surface and in fluid communication with the outlet opening; and

a first tissue protection structure configured to be positioned below the lower surface of the elongate conduit structure.

2. The elongate conduit structure of claim 1 , further comprising:

an adhesive structure coupled to at least one of the lower surface of the elongate conduit structure and the first tissue protection structure; and

a release liner adhered to the adhesive structure, wherein the release liner comprises a release surface in contact with the adhesive structure, and wherein a second tissue protection structure is on an opposite surface from the release surface.

3. The elongate conduit structure of claim 2 , wherein the release liner extends beyond an edge of the adhesive structure.

4. The elongate conduit structure of claim 2 , wherein the first tissue protection structure comprises a different material than the second tissue protection structure.

5. The elongate conduit structure of claim 2 , wherein the first tissue protection structure comprises a foam.

6. The elongate conduit structure of claim 2 , wherein the second tissue protection structure comprises a woven material.

7. The elongate conduit structure of claim 1 , wherein the support structure comprises a foam.

8. The elongate conduit structure of claim 2 , wherein the adhesive structure is attached to the first tissue protection structure.

9. The elongate conduit structure of claim 1 , wherein the inlet opening is located at a distal region of the elongate conduit structure.

10. The elongate conduit structure of claim 9 , wherein the outlet opening is located at a proximal region of the elongate conduit structure.

11. The elongate conduit structure of claim 9 , wherein the outlet opening is located between a proximal region of the elongate conduit structure and the distal region of the elongate conduit structure.

12. The elongate conduit structure of claim 2 , wherein the upper surface and the lower surface are integrally formed.

13. The elongate conduit structure of claim 2 , wherein the upper surface and the lower surface form a seam along an outer perimeter of the elongate conduit structure.

14. The elongate conduit structure of claim 13 , wherein the upper surface comprises a non-planar, vacuum formed polymeric structure, and wherein the lower surface comprises a planar polymeric structure.

15. The elongate conduit structure of claim 2 , wherein the dressing is attached to the elongate conduit structure at the inlet opening.

16. The elongate conduit structure of claim 1 , wherein an edge of the dressing is aligned with an edge of the first tissue protection structure.

17. The elongate conduit structure of claim 1 , wherein the dressing does not overlap with the first tissue protection structure.

18. The elongate conduit structure of claim 1 , wherein the first tissue protection structure comprises a lateral perimeter portion that extends beyond a lateral perimeter of the elongate conduit structure.

19. A method to treat tissue, the method comprising:

attaching at least one wound cover having an elongated conduit to a treatment site, wherein the elongated conduit is pre-coupled between the at least one wound cover and a tube that extends to a vacuum source, the elongated conduit comprising:

an upper surface and a lower surface each extending along a longitudinal length of the elongated conduit,

a longitudinal passageway that extends along the longitudinal length of the elongated conduit and between the upper surface and the lower surface,

an inlet opening located in the lower surface,

an outlet opening located in the upper surface,

a support structure defining parallel channels through the longitudinal passageway, wherein each of the parallel channels extends from the inlet opening to the outlet opening, and wherein the support structure comprises one or more elongate ribs coupled to at least one of the upper surface or the lower surface,

a port coupled to the upper surface and in fluid communication with the outlet opening, and

a first tissue protection structure configured to be positioned below the lower surface of the elongated conduit;

externally compressing the elongated conduit;

attaching the vacuum source to the elongated conduit; and

activating the vacuum source after externally compressing the elongated conduit.

20. The method of claim 19 , further comprising maintaining at least some external compression of the elongated conduit while activating the vacuum source.

21. The elongate conduit structure of claim 1 , further comprising a support configured to maintain fluid communication between the inlet opening and the parallel channels under an external force.

22. The elongate conduit structure of claim 1 , wherein the first tissue protection structure is porous.

23. The elongate conduit structure of claim 2 , wherein the second tissue protection structure is porous.

24. The elongate conduit structure of claim 1 , wherein the support structure maintains the parallel channels in a parallel configuration through the longitudinal passageway.

25. The method of claim 19 , wherein the upper surface and the lower surface are impermeable.

Assignments (11)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066443/0513 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064730/0636 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2015
From: SPIRACUR INC.
To: KCI LICENSING, INC.
Reel/Frame 037355/0210 →
RELEASE OF SECURITY INTEREST Recorded Dec 1, 2015
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC
To: SPIRACUR INC.
Reel/Frame 037179/0541 →
ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 14, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
Reel/Frame 037111/0836 →
SECURITY INTEREST Recorded Oct 30, 2014
From: SPIRACUR INC., AS GRANTOR
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 034076/0087 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2012
From: WU, KENNETH; NG, DARREN; LEE, JENNIFER; HU, DEAN
To: SPIRACUR INC.
Reel/Frame 028972/0437 →